Approximately one in seven cancers contains a mutation at codon 12, 13, or 61 in the KRAS gene, which renders the protein predominantly nucleotide guanosine triphosphate (GTP) bound and hence active and oncogenic [2, 3, 4, 5]. The gene discussed is KRAS; the disease is cancer.